Abstract
To simulate new strategies for designing effective drugs against bird flu, we have carried out extensive studies by using various computer-aided drug design tools. Molecule AG7088 was first docked to the active site of H5N1 avian influenza neuraminidase (PBD code: 2HTY). The results thus obtained were compared with those by docking zanamivir (Relenza) and oseltamivir (Tamiflu) to the same receptor, respectively. It has been found that the compound AG7088 has better binding energy than zanamivir and oseltamivir. Thus, it was adopted as a template to perform the similarity search of 392,698 druggable compounds in order to find the leading candidates for the next step of modeling studies. Nine analogs of AG7088 were singled out through a series of docking studies. Finally, the molecular dynamics simulation technique was utilized to investigate into the binding interactions between the H5N1 receptor and the nine analogs, with a focus on the binding pocket, intermolecular surfaces and hydrogen bonds. This study may be used as a guide for mutagenesis studies for designing new inhibitors against H5N1.
Keywords: H5N1, avian influenza, bird flu, drug design, neuraminidase, structural bioinformatics, active site, AG7088
Medicinal Chemistry
Title: Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design
Volume: 5 Issue: 3
Author(s): Ke Gong, Lin Li, Jing-Fang Wang, Feng Cheng, Dong-Qing Wei and Kuo-Chen Chou
Affiliation:
Keywords: H5N1, avian influenza, bird flu, drug design, neuraminidase, structural bioinformatics, active site, AG7088
Abstract: To simulate new strategies for designing effective drugs against bird flu, we have carried out extensive studies by using various computer-aided drug design tools. Molecule AG7088 was first docked to the active site of H5N1 avian influenza neuraminidase (PBD code: 2HTY). The results thus obtained were compared with those by docking zanamivir (Relenza) and oseltamivir (Tamiflu) to the same receptor, respectively. It has been found that the compound AG7088 has better binding energy than zanamivir and oseltamivir. Thus, it was adopted as a template to perform the similarity search of 392,698 druggable compounds in order to find the leading candidates for the next step of modeling studies. Nine analogs of AG7088 were singled out through a series of docking studies. Finally, the molecular dynamics simulation technique was utilized to investigate into the binding interactions between the H5N1 receptor and the nine analogs, with a focus on the binding pocket, intermolecular surfaces and hydrogen bonds. This study may be used as a guide for mutagenesis studies for designing new inhibitors against H5N1.
Export Options
About this article
Cite this article as:
Gong Ke, Li Lin, Wang Jing-Fang, Cheng Feng, Wei Dong-Qing and Chou Kuo-Chen, Binding Mechanism of H5N1 Influenza Virus Neuraminidase with Ligands and its Implication for Drug Design, Medicinal Chemistry 2009; 5 (3) . https://dx.doi.org/10.2174/157340609788185936
DOI https://dx.doi.org/10.2174/157340609788185936 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
Call for Papers in Thematic Issues
Carbohydrates in Computational and Medicinal Chemistry
Carbohydrates are the most essential organic molecules and are involved in the maintenance of various physiological and metabolic processes in living organisms. Carbohydrate-based compounds have come to the attention of researchers because of their significant contributions to biological functions, such as cell development and cell proliferation, connections between several cells, ...read more
Recent Advances in the Medicinal Chemistry of Cancer
Scope of the Thematic Issue: Correlation between structure and function is one of the important aspects of the success of anti-cancer compounds associated with their structure-activity interactions, physiology, biochemical, molecular, and genetic processes. Overcoming these obstacles is key to obtaining further insights into developments in rational drug design, bioorganic chemistry, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions
Current Drug Targets Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
Current Drug Targets DI-2-Ethylhexyl Phthalate and Endocrine Disruption: A Review
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Impact of Crystallographic Data for the Development of Machine Learning Models to Predict Protein-Ligand Binding Affinity
Current Medicinal Chemistry Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties
Current Alzheimer Research HPLC-fluorescence Determination of EROD Activity in Wistar Rat Liver Microsomes Obtained by Two Different Extraction Procedures
Current Pharmaceutical Analysis Impact of Nutrition in the Management of Nutritional Status of Covid-19 Patients
Current Nutrition & Food Science Brain Drug Delivery: Overcoming the Blood-brain Barrier to Treat Tauopathies
Current Pharmaceutical Design Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
Coronaviruses Computational Investigation of Ligand Binding of Flavonoids in Cytochrome P450 Receptors
Current Pharmaceutical Design IoT Solutions for Smart Management of Hospital Buildings: A General Review towards COVID-19, Future Pandemics, and Infectious Diseases
Current Signal Transduction Therapy Brevifoliol and its Analogs: A New Class of Anti-tubercular Agents
Current Topics in Medicinal Chemistry Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein
Infectious Disorders - Drug Targets Anti-MRSA (Multidrug Resistant Staphylococcus aureus) Activity of 3-Substituted Coumarins
Letters in Drug Design & Discovery Recent Developments of Small Molecule PI3K/mTOR Dual Inhibitors
Mini-Reviews in Medicinal Chemistry The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System
Current Neuropharmacology What we have Learned from Animal Models of Mycoplasma pneumoniae Disease: Virulence Mechanisms and Host Responses
Current Pediatric Reviews The Oxygen Therapy
Current Medicinal Chemistry Dipyridodiazepinone Analogs as Human Immunodeficiency Virus Type 1- Specific Non-Nucleoside Reverse Transcriptase Inhibitors: An Overview
Current Medicinal Chemistry Sarcosine-Based Glycine Transporter Type-1 (GlyT-1) Inhibitors Containing Pyridazine Moiety: A Further Search for Drugs with Potential to Influence Schizophrenia Negative Symptoms
Current Pharmaceutical Design